HIV-1 and HIV-2 protease inhibitor, frequently used in immunometabolism research.
Potentially binds and inhibits the CEP_C30 (coronavirus endopeptidase C30) of SARS-CoV-2 and when used with lopinavir has shown to improve animal models of MERS-CoV.
Also shows antitumour activity and induces apoptosis.
Solubility & Handling
Storage instructions
-20°C
Solubility overview
Soluble in DMSO (20mM, gentle warming) and ethanol (10mM)
Important
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use
References are publications that support the biological activity of the product
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Beck BR et al (2020) Comput Struct Biotechnol J 18 : 784-790